tiprankstipranks
Teva Pharmaceutical Industries Limited (IL:TEVA)
:TEVA
Israel Market

Teva (TEVA) Financial Statements

Compare
3 Followers

Teva Financial Overview

Teva's market cap is currently 68.26B. The company's EPS TTM is -5.377; its P/E ratio is ―; Teva is scheduled to report earnings on January 29, 2025, and the estimated EPS forecast is 182.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 15.85B$ 14.93B$ 15.88B$ 16.66B$ 16.89B
Gross Profit$ 7.65B$ 6.97B$ 7.59B$ 7.72B$ 7.54B
Operating Income$ 433.00M$ -2.10B$ 1.72B$ -3.57B$ -443.00M
EBITDA$ 1.56B$ -925.00M$ 4.41B$ -1.95B$ 1.28B
Net Income$ -559.00M$ -2.35B$ 417.00M$ -3.99B$ -999.00M
Balance Sheet
Cash & Short-Term Investments$ 3.23B$ 2.80B$ 2.17B$ 2.18B$ 1.98B
Total Assets$ 43.48B$ 44.01B$ 47.67B$ 50.64B$ 57.47B
Total Debt$ 20.15B$ 21.56B$ 23.46B$ 26.40B$ 27.34B
Net Debt$ 16.93B$ 18.76B$ 21.29B$ 24.22B$ 25.37B
Total Liabilities$ 35.35B$ 35.31B$ 36.42B$ 39.58B$ 42.41B
Stockholders' Equity$ 7.51B$ 7.90B$ 10.28B$ 10.03B$ 13.97B
Cash Flow
Free Cash Flow$ 842.00M$ 1.04B$ 236.00M$ 638.00M$ 419.00M
Operating Cash Flow$ 1.37B$ 1.59B$ 798.00M$ 1.22B$ 538.00M
Investing Cash Flow$ 968.00M$ 656.00M$ 1.52B$ 863.00M$ 430.00M
Financing Cash Flow$ -1.91B$ -1.49B$ -2.17B$ -1.89B$ -241.00M
Currency in USD

Teva Earnings and Revenue History

Teva Debt to Assets

Teva Cash Flow

Teva Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis